How Teva Pharmaceutical is managing third-party risk better | EY - Global
Teva Pharmaceutical, Owner of Frazer's Cephalon, Forms Joint Venture With Japanese Drug Firm
/arc-anglerfish-arc2-prod-pmn.s3.amazonaws.com/public/QLOB6IH57ZGW3NM55HWQDLO2BU.jpg "Teva Pharmaceutical Industries names a new CEO")
Teva Pharmaceutical Industries names a new CEO
Definitive Proxy Statement
Teva fueled opioid addiction in New York state, jury finds | Business and Economy News | Al Jazeera
Teva sheds logistics center for $127M after 2 about-faces | Fierce Pharma
Teva shares surge after announcing global opioid settlement
What To Do After TEVA Stock Falls Below $10 Again (NYSE:TEVA) | Seeking Alpha
Maryland charges pharmaceutical companies for role in opioid epidemic – Baltimore Sun
What's Next For Teva Pharmaceutical Stock After A 17% Fall In A Month?
Teva, with a $4.25B opioid settlement in hand, eyes return to growth by 2027 | Fierce Pharma
Teva Pharmaceuticals - Wikipedia
How Teva Pharmaceutical is managing third-party risk better | EY - Global
DEF 14A
Teva Pharmaceuticals and State Responsible for Opioid Epidemic in NY, Jury Finds - Top Class Actions
Generics distributor Anda, Inc. has a new owner: Teva Pharma
Teva cleared in French switched drug packaging investigation - Jewish Business News
Rhode Island takes Teva to trial in multibillion-dollar opioid case | Reuters
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business
Teva Pharmaceuticals - Wikipedia
TEVA Pharmaceuticals sells Forest facility to private investor | WSET
Allergan sells generic drug unit to Israel's Teva for $40.5 billion - Los Angeles Times
Teva Pharmaceutical Industries Ltd fueled opioid addiction, court rules | Fox Business
TEVA Pharmaceuticals, Waterford - - Projectdetails
New York court dismisses most of Teva claims against Mexican drugmakers | The Times of Israel
